CytomX Therapeutics, Inc. — All Filings
762 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| D | — | 0001501989-15-000001 | Jan 6, 2015 | — |
| D | — | 0001501989-12-000002 | Aug 10, 2012 | — |
| D | — | 0001501989-10-000005 | Sep 28, 2010 | — |
| D | — | 0001501989-10-000004 | Sep 28, 2010 | — |
| D | — | 0001501989-10-000003 | Sep 28, 2010 | — |
| D | — | 0001501989-10-000002 | Sep 28, 2010 | — |
| D | — | 0001501989-10-000001 | Sep 28, 2010 | — |